These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33423668)

  • 1. Transjugular intrahepatic portosystemic shunt for hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum.
    Zhang L; Li Q; Makamure J; Zhao D; Liu Z; Zheng C; Liang B
    BMC Gastroenterol; 2021 Jan; 21(1):26. PubMed ID: 33423668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transjugular Intrahepatic Portosystemic Shunt Benefits for Hepatic Sinusoidal Obstruction Syndrome Associated with Consumption of Gynura Segetum: a Propensity Score-Matched Analysis.
    Li S; Li Y; Zhou C; Li H; Chen C; Peng C; Wang T; Liu F; Xiao J; Shi L
    Cardiovasc Intervent Radiol; 2023 Jul; 46(7):931-942. PubMed ID: 37225971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors of poor prognosis in patients with pyrrolidine alkaloid-induced hepatic sinusoidal obstruction syndrome after transjugular intrahepatic portosystemic shunt.
    Xiao J; Tu J; Zhang H; Zhang F; Zhang W; Xu H; Yin Q; Yang J; Han H; Wang Y; Zhang B; Peng C; Zou X; Zhang M; Zhuge Y
    Hepatol Int; 2021 Jun; 15(3):720-729. PubMed ID: 33507485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rare case of Gynura-segetum-related hepatic sinus obstruction syndrome complicated with alcoholic liver disease.
    Gao Y; Zhang X; Zhou X; Wang J; Gong L; Chen G
    J Pak Med Assoc; 2024 Jul; 74(7):1355-1357. PubMed ID: 39028070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transjugular intrahepatic portosystemic shunt for pyrrolizidine alkaloid-related hepatic sinusoidal obstruction syndrome.
    Zhou CZ; Wang RF; Lv WF; Fu YQ; Cheng DL; Zhu YJ; Hou CL; Ye XJ
    World J Gastroenterol; 2020 Jun; 26(24):3472-3483. PubMed ID: 32655270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of PA-HSOS severity grading to predict the prognosis of patients with PA-HSOS treated by transjugular intrahepatic portosystemic shunt].
    Chen YR; Zhang W; Zhang M; Zhang F; Xiao JQ; Yin Q; Zhuge YZ
    Zhonghua Gan Zang Bing Za Zhi; 2021 Jan; 29(1):46-53. PubMed ID: 33541023
    [No Abstract]   [Full Text] [Related]  

  • 7. Transjugular intrahepatic portosystemic shunt for pyrrolidine alkaloids-induced hepatic sinusoidal obstruction syndrome: a retrospective cohort study.
    Huang T; Zhang X; Yan K; Lou D; He Y; Dai S; Zheng D; Chen P; Wu F; Gu L
    Eur J Gastroenterol Hepatol; 2023 Sep; 35(9):1004-1011. PubMed ID: 37395216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing and efficacy of transjugular intrahepatic portosystemic shunt in patients with pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome.
    Wu F; Yu J; Gan H; Zhang H; Tian D; Zheng D
    Sci Rep; 2021 Nov; 11(1):21743. PubMed ID: 34741082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for hepatic veno-occlusive disease caused by Gynura segetum: a retrospective study.
    Wang Y; Qiao D; Li Y; Xu F
    BMC Gastroenterol; 2018 Oct; 18(1):156. PubMed ID: 30367628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide.
    Gómez-Centurión I; Bailén R; Oarbeascoa G; Muñoz C; Luque AÁ; Boyra ME; Calleja E; Rincón D; Dorado N; Barzallo P; Anguita J; Díez-Martín JL; Kwon M
    Biol Blood Marrow Transplant; 2020 Nov; 26(11):2089-2097. PubMed ID: 32791193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic, totally occluded, portal vein thrombosis with symptomatic portal hypertension: procedure technique, safety, and clinical applications.
    Chen Y; Ye P; Li Y; Ma S; Zhao J; Zeng Q
    Eur Radiol; 2015 Dec; 25(12):3431-7. PubMed ID: 25903717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
    Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
    World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mid- to long-term outcomes of initial transjugular intrahepatic portosystemic shunt versus anticoagulation for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome.
    Huang Q; Zhang Q; Xu H; Zu M; Xiao J; Shen B
    Eur J Gastroenterol Hepatol; 2023 Apr; 35(4):445-452. PubMed ID: 36719828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the efficacy of TIPS in 27 patients with hepatic sinus obstruction syndrome in the near and medium term].
    Wang L; Zhang Y; Wang XQ; Yue ZD; Fan ZH; Wu YF; Liu FQ; Dong J; Zhang K; Jiang L; Ding HG; Zhang YN
    Zhonghua Gan Zang Bing Za Zhi; 2023 Aug; 31(8):842-846. PubMed ID: 37723066
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation--role of transjugular intrahepatic portosystemic shunt (TIPS).
    Zenz T; Rössle M; Bertz H; Siegerstetter V; Ochs A; Finke J
    Liver; 2001 Feb; 21(1):31-6. PubMed ID: 11169070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gynura Segetum Related Hepatic Sinusoidal Obstruction Syndrome: A Liver Disease with High Mortality and Misdiagnosis Rate.
    Ou P; Liu X; Tang Z; Hou Z; Liu L; Liu J; Zhou S; Fang Z; Sun K; Chen Y; Chen X; Li Y; Chen J
    Curr Pharm Des; 2019; 25(35):3762-3768. PubMed ID: 31589115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transjugular liver biopsy after transjugular intrahepatic portosystemic shunt (TIPS) or direct intrahepatic portocaval shunt (DIPS): Is it feasible, effective, and safe?
    Kaufman C; Aryafar H; Minocha J; Kinney T
    Diagn Interv Imaging; 2018 May; 99(5):331-335. PubMed ID: 29366793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing Affects Measurement of Portal Pressure Gradient After Placement of Transjugular Intrahepatic Portosystemic Shunts in Patients With Portal Hypertension.
    Silva-Junior G; Turon F; Baiges A; Cerda E; García-Criado Á; Blasi A; Torres F; Hernandez-Gea V; Bosch J; Garcia-Pagan JC
    Gastroenterology; 2017 May; 152(6):1358-1365. PubMed ID: 28130066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transjugular Intrahepatic Portosystemic Shunt Through the Strut of a Previously Placed Stent: Technical Feasibility and Long-Term Follow-Up Results.
    Ahmed M; Keshava SN; Moses V; Chiramel GK; Mammen S; Eapen CE; Zachariah UG
    Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1794-1798. PubMed ID: 30014251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transjugular intrahepatic portosystemic shunt for severe jaundice in patients with acute Budd-Chiari syndrome.
    He FL; Wang L; Zhao HW; Fan ZH; Zhao MF; Dai S; Yue ZD; Liu FQ
    World J Gastroenterol; 2015 Feb; 21(8):2413-8. PubMed ID: 25741149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.